Immunophenotype Expression Change From CD52+ to CD52- on Erythrodermic Peripheral T-cell Lymphoma, Not Otherwise Specified After Treatment With Alemtuzumab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of dermatopathology 2018-07, Vol.40 (7), p.547-550
Hauptverfasser:	Dhandha, Maulik M, Sufficool, Kari E, Vidal, Claudia I, Robbins, Katherine J, Fesler, Mark J, Batanian, Jacqueline R, Hurley, Maria Yadira
Format:	Artikel
Sprache:	eng
Schlagworte:	Alemtuzumab - therapeutic use Antibodies, Monoclonal - therapeutic use Biopsy, Needle CD52 Antigen - genetics CD52 Antigen - metabolism Female Follow-Up Studies Gene Expression Regulation Humans Immunohistochemistry Immunophenotyping - methods Lymphoma, T-Cell, Peripheral - drug therapy Lymphoma, T-Cell, Peripheral - genetics Lymphoma, T-Cell, Peripheral - pathology Male Molecular Targeted Therapy - methods Risk Assessment Skin Neoplasms - drug therapy Skin Neoplasms - genetics Skin Neoplasms - pathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!